dr. F.G.G. (Elisabeth ) Bakkers

dr. F.G.G. (Elisabeth ) Bakkers

Full Professor
dr. F.G.G. (Elisabeth ) Bakkers
  • Onderzoek



Dr. Prof. Elisabeth AM Sanders (F), born in 1959 is paediatrician and Professor in Pediatric Immunology and Infectious Diseases at the University Medical Center Utrecht in combination with a position as Chief Science Officer (Immunology, Infectiology and Vaccinology) at the Netherlands National Institute for Public Health and Environment (RIVM). She has a H-index of 38 and wrote over 250 peer reviewed manuscripts in international journals . She was head of the clinical department of Immunology and Infectious Diseases of the University Children’s Hospital Utrecht between 2004-2009. Between 2009 -2014 she was director Research and Education of the University Hospital for Children in Utrecht. She has a long standing interest in the clinical effectiveness of vaccines, prevention of respiratory infections and development of microbiome and immunity in children. At present, her research focus is  optimizing current national vaccination programmes for children and elderly, epidemiology and prevention of respiratory tract infections and respiratory microbiome profile development in health and disease.

Since 2010, she is a member of the Health Council for the Ministry of Health. She has participated in many scientific advisory boards for the national Health Council.

Side Activities


2021-   Consultant (geraadpleegd deskundige) National Health Council  on COVID-19 vaccination strategies (gezondheidsraad COVID-19 vaccinatie)

2021-  (co-)Director wetenschappelijk inhoudelijk COVID-19 vaccinatie programma RIVM (naast Hans van Vliet)

2020-   Consultant Outbreak Management Team on SARS-CoV-2/COVID-19

2019 -   Co-initiator of IGJ AIOS Conference (since 2017, twice a year) with the aim of improved interaction between Inspection (IGJ) and doctors in training

2019 -   Member NWO selection Committee VIDI candidates

2019-    Member of Conference Committee National Society for Paediatrics in the Netherlands, NVK

2017-    Member of the International Coalition for Life Course Immunization (CLCI)

2016-    WHO: Member of WHO SAGE working group on pneumococcal vaccines

2016 - 2018      Member of Faculty Masterclasses Vaccinology

2016 -               Observer at the JCVI meetings (3-4 times per year), UK

2010 - 2018      Member of the Health Council

2011 - 2015      National Pediatric Society (NVK); board member scientific committee

2007 - 2015      Member Health Council of the Netherlands; Member of the council group (Beraadgroep) on Infections and Immunity

2013 - 2014      Health Council of the Netherlands; member of the council committee on the national program for FLU vaccination.

2013 - 2014      Health Council of the Netherlands; member of the council committee on the national immunization program (Commission RVP) of the National Health Council.

2005 - 2014      Stichting Afweerstoornissen, SAS, Chair scientific advice committee Patient Society for Immunodeficiency disease. 

2001 - 2013      Board member responsible for the Organization of the scientific meetings of the Interuniversity working party for the Study of Immune deficiencies

2013       Member NWO VENI  selection committee

2013       Member scientific board ISPPD conference India, March 2014

2007 - 2012          KNAW- Royal Netherlands Academy of Arts and Sciences, Chair of the Scientific Advisory Board of the TerMeulenFonds” –

2012    World Health Organization meeting PneumoCarr March 27-28th in Geneva, March 27/28.

2003 - 2012      Dutch Society of Pediatrics, NVK, member of the selection committee for the Young Investigators Award

2011    Health Council of the Netherlands, member of the council committee on population screening for cervical cancer.

2011     Member scientific committee ESPID conference June 2011

2010     National Health Council Advisory member of the committee on vaccination of newborns against pneumococcal infections

2003 - 2009      Member of the Board of Trustees of the National Vaccine Institute, NVI

2009      National Health Council Advisory member of the committee on vaccination against pandemic Flu.

2004 - 2008     KNAW- Royal Netherlands Academy of Arts and Sciences. Member of the scientific Advisory Board of the TerMeulen Fonds –

1997 - 2007     Board member/Treasurer of the Pediatric Immunology Section of the Dutch Society of Pediatrics

2002    Committee for the Ministry of Health, for the National Vaccination Program regarding pneumococcal and Meningococcal C vaccinations, advisory member.

2001    Member Cochrane Collaboration on Pneumococcal Vaccines and Otitis Media

Potential Conflicts of Interest

Besides her function as Professor at the University of Utrecht and position (0.2 Fte) at the Wilhelmina Children’s Hospital, Lieke Sanders has a full-time position at the National Institute of Public Health and the Environment (RIVM) as Chief Science Officer since December 2014. Since January 2021 she is co-medical director of the COVID-19 vaccination programme at RIVM. She is member of the WHO-SAGE committee on pneumococcal vaccinations, consultant for the national Health Council committee for COVID-19 vaccination (incidenteel geraadpleegd deskundige) without any personal fee or benefit.  

Dr Sanders has no research connections with pharmaceutical or industrial partners since 2014, besides as research partner in IMI-funded studies RESCEU and PROMISE projects with partners GSK, Novavax, Janssen, AstraZeneca, Pfizer and Sanofi. She receives no personal fees or other personal benefits from any collaboration as RIVM partner in these studies or research.

No other conflict of interest to report.

Fellowship and Awards


Research Output (500)

Effects of early-life antibiotics on the developing infant gut microbiome and resistome:a randomized trial

Reyman Marta, van Houten Marlies A., Watson Rebecca L., Chu Mei Ling J.N., Arp Kayleigh, de Waal Wouter J., Schiering Irene, Plötz Frans B., Willems Rob J.L., van Schaik Willem, Sanders Elisabeth A.M., Bogaert Debby 16 Feb 2022, In: Nature Communications. 13

Salivary antibody responses to ten-valent pneumococcal conjugate vaccination following two different immunization schedules in a healthy birth cohort

de Koff Emma M., van Houten Marlies A., de Heij Femke, Berbers Guy A.M., Bogaert Debby, Sanders Elisabeth A.M. 24 Jan 2022, In: Vaccine. 40 , p. 408-413 6 p.

Topical or oral antibiotics for children with acute otitis media presenting with ear discharge:study protocol of a randomised controlled non-inferiority trial

Hullegie Saskia, Venekamp Roderick P, van Dongen Thijs M A, Mulder Sanne, van Schaik Willem, de Wit G Ardine, Hay Alastair D, Little Paul, Moore Michael V, Sanders Elisabeth A M, Bonten Marc J M, Bogaert Debby, Schilder Anne Gm, Damoiseaux Roger A M J 16 Dec 2021, In: BMJ Open. 11

Study protocol of the PIMPI-project, a cohort study on acceptance, tolerability and immunogenicity of second trimester maternal pertussis immunization in relation to term and preterm infants

Immink Maarten M., Bekker Mireille N., de Melker Hester E., Rots Nynke Y., Sanders Elisabeth A.M., van der Maas Nicoline A.T. Dec 2021, In: BMC Infectious Diseases. 21 , p. 1-9

Detection of Neisseria meningitidis in saliva and oropharyngeal samples from college students

Miellet Willem R., Mariman Rob, Pluister Gerlinde, de Jong Lieke J., Grift Ivo, Wijkstra Stijn, van Logchem Elske M., van Veldhuizen Janieke, Immink Marie Monique, Wijmenga-Monsuur Alienke J., Rots Nynke Y., Sanders Elisabeth A.M., Bosch Thijs, Trzciński Krzysztof 30 Nov 2021, In: Scientific Reports. 11 , p. 1-9

Trends in measles incidence and measles vaccination coverage in Nigeria, 2008–2018

Jean Baptiste Anne Eudes, Masresha Balcha, Wagai John, Luce Richard, Oteri Joseph, Dieng Boubacar, Bawa Samuel, Ikeonu Obianuju Caroline, Chukwuji Martin, Braka Fiona, Sanders E. A.M., Hahné Susan, Hak Eelko 17 Nov 2021, In: Vaccine. 39 , p. C89-C95

Influenza-like Illness Exacerbates Pneumococcal Carriage in Older Adults

Miellet Willem R., Van Veldhuizen Janieke, Nicolaie Mioara A., Mariman Rob, Bootsma Hester J., Bosch Thijs, Rots Nynke Y., Sanders Elisabeth A.M., Van Beek Josine, Trzciński Krzysztof 1 Nov 2021, In: Clinical Infectious Diseases. 73 , p. E2680-E2689

More than 10 years after introduction of an acellular pertussis vaccine in infancy:a cross-sectional serosurvey of pertussis in the Netherlands

Versteegen Pauline, Berbers Guy A.M., Smits Gaby, Sanders Elisabeth A.M., van der Klis Fiona R.M., de Melker Hester E., van der Maas Nicoline A.T. Nov 2021, In: The Lancet Regional Health - Europe. 10 , p. 1-9

A novel method to standardise serum IgA measurements shows an increased prevalence of IgA deficiency in young children with recurrent respiratory tract infections

Koenen Mischa, Bosma Marleen, Roorda Udo, Wopereis Fabienne, Roos Anja, van der Vries Erhard, Bogaert D, Sanders Elisabeth , Boes Marianne, Heidema Jojanneke, van Montfrans JM, Balemans Walter A F, van Holten Thijs C, Verhagen Lilly 29 Oct 2021, In: Clinical and Translational Immunology. 10 10 p.

Microbial community networks across body sites are associated with susceptibility to respiratory infections in infants

Reyman Marta, Clerc Melanie, van Houten Marlies A., Arp Kayleigh, Chu Mei Ling J.N., Hasrat Raiza, Sanders Elisabeth A.M., Bogaert Debby 28 Oct 2021, In: Communications biology. 4

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not